Fatal disseminated adenoviral infection in an adult heart transplant patient.

Department of Pathology, University of Texas-Houston, Houston, Texas, USA.
The Journal of Heart and Lung Transplantation (Impact Factor: 5.11). 11/2004; 23(10):1209-12. DOI: 10.1016/j.healun.2003.08.026
Source: PubMed

ABSTRACT In heart transplant recipients, infection is one of the leading causes of morbidity and mortality. In adult heart transplant patients, cytomegalovirus is the most frequently encountered viral pathogen. Conversely, disseminated adenoviral infection is observed mainly in children, where it is predictive of allograft rejection and coronary vasculopathy. The literature contains only a few reports of adenoviral infections in adult heart transplant recipients. Limited information is available concerning the diagnosis and epidemiology of such infections and their relationship to organ rejection, heart failure and overall outcomes in these patients. To promote an awareness of this potentially lethal complication, we present a case of fatal disseminated adenoviral infection in an adult heart transplant recipient.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Concerns over the safety of conventional viral vectors have limited the translation of gene transfer from an exciting experimental procedure to a successful clinical therapy in transplantation. Baculoviruses are insect viruses, but have the ability to enter mammalian cells and deliver potential therapeutic molecules with no evidence of viral replication. This study provides evidence of the ability of recombinant baculovirus to enter mammalian kidneys and livers during cold preservation. Six kidneys and six liver lobules retrieved from large pigs were perfused with University of Wisconsin (UW) solution containing a baculovirus tagged with green fluorescent protein and preserved for 8 h. In addition, six kidneys were perfused with UW containing a baculovirus expressing red fluorescent protein and preserved for 24 h. Green fluorescent virus particles were detected within transduced kidneys and livers after 8 h standard cold storage and red fluorescent protein mRNA was detected in kidneys after 24 h of cold preservation. There were no significant differences in tissue architecture, cell morphology or ATP content between experimental organs and their controls. Ex vivo transduction of organs with recombinant baculovirus during conventional cold preservation was demonstrated with no evidence of additional injury or reduction in cell viability.
    Transplant International 05/2011; 24(8):820-8. · 3.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Adenovirus infections have been associated with significant morbidity and mortality in immunocompromised hosts. The clinical significance of adenoviral disease in heart transplantation is not well defined; in particular, the significance of adenovirus identification in myocardium remains unclear. Although severe adenovirus disease has been described in heart transplant recipients, adenovirus infections seem to be more frequently associated with increased risk of adverse cardiac events such as rejection, ventricular dysfunction, coronary vasculopathy, need for re-transplantation and graft loss because of death. Cidofovir is currently considered the standard of treatment for adenovirus disease not responding to reduction of immunosuppression.
    Cardiology in review 03/2013;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To describe the demographics, clinical manifestations, treatment and outcomes of patients with human adenovirus (HAdV) hepatitis. A case of fulminant HAdV hepatitis in a patient with chronic lymphocytic leukemia receiving rituximab and fludarabine is described. We conducted a comprehensive review of the English-language literature through May, 2012 in search of definite cases of HAdV hepatitis. Eighty-nine cases were reviewed. Forty-three (48 %) were liver transplant recipients, 19 (21 %) were bone marrow transplant recipients, 11 (12 %) had received chemotherapy, five (6 %) had severe combined immunodeficiency, four (4 %) were HIV infected, two had heart transplantation, and two were kidney transplant recipients. Ninety percent (46/51) of patients presented within 6 months following transplantation. Fever was the most common initial symptom. Abdominal CT scan revealed hypodense lesions in eight of nine patients. Diagnosis was made by liver biopsy in 43 (48 %), and on autopsy in 46 (52 %). The HAdV was isolated at other sites in 54 cases. Only 24 of 89 patients (27 %) survived: 16 whose immunosuppression was reduced, six with liver re-transplantation, and two who received cidofovir and intravenous immunoglobulin. HAdV hepatitis can manifest as a fulminant illness in immunocompromised hosts. Definitive diagnosis requires liver biopsy. Early consideration of a viral etiology, reduction in immunosuppression, and liver transplantation can be potentially life-saving.
    Infection 08/2013; · 2.44 Impact Factor